{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:23:16Z","timestamp":1772166196188,"version":"3.50.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T00:00:00Z","timestamp":1599177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T00:00:00Z","timestamp":1599177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100001448","name":"Alpha-1 Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001448","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Alpha-1 antitrypsin deficiency (AATD)-mediated liver disease is a toxic \u201cgain-of-function\u201d inflammation in the liver associated with intracellular retention of mutant alpha-1 antitrypsin. The clinical presentation of the disease includes fibrosis, cirrhosis and liver failure. However, the pathogenic mechanism of AATD-mediated liver disease is not well understood. Here, we investigated the role of plasma extracellular vesicles (EVs) in progression of AATD-mediated liver disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>EVs were isolated from plasma of AATD individuals with liver disease and healthy controls. Their cytokines and miRNA content were examined by multiplex assay and small RNA sequencing. The bioactivity of EVs was assessed by qPCR, western blot analysis and immunofluorescent experiments using human hepatic stellate cells (HSCs) treated with EVs isolated from control or AATD plasma samples.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We have found that AATD individuals have a distinct population of EVs with pathological cytokine and miRNA contents. When HSCs were cultured with AATD plasma derived-EVs, the expression of genes related to the development of fibrosis were significantly amplified compared to those treated with healthy control plasma EVs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>AATD individuals have a distinct population of EVs with abnormal cytokine and miRNA contents and the capacity to activate HSCs and mediate fibrosis. Better understanding of the components which cause liver inflammation and fibrogenesis, leading to further liver injury, has the potential to lead to the development of new treatments or preventive strategies to prevent AATD-mediated liver disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12964-020-00648-0","type":"journal-article","created":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T09:02:47Z","timestamp":1599210167000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Alpha-1 antitrypsin deficient individuals have circulating extracellular vesicles with profibrogenic cargo"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4659-1622","authenticated-orcid":false,"given":"Nazli","family":"Khodayari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regina","family":"Oshins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. Shannon","family":"Holliday","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Marek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Borna","family":"Mehrad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Brantly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,4]]},"reference":[{"issue":"11","key":"648_CR1","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1172\/JCI0216787","volume":"110","author":"DH Perlmutter","year":"2002","unstructured":"Perlmutter DH. Liver injury in alpha1-antitrypsin deficiency: an aggregated protein induces mitochondrial injury. J Clin Invest. 2002;110(11):1579\u201383.","journal-title":"J Clin Invest"},{"issue":"8","key":"648_CR2","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.4049\/jimmunol.1801045","volume":"202","author":"EP Reeves","year":"2019","unstructured":"Reeves EP, Dunlea DM, McQuillan K, O'Dwyer CA, Carroll TP, Saldova R, et al. Circulating truncated Alpha-1 antitrypsin glycoprotein in patient plasma retains anti-inflammatory capacity. J Immunol. 2019;202(8):2240\u201353.","journal-title":"J Immunol"},{"issue":"10","key":"648_CR3","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/jcp.2008.063495","volume":"62","author":"NA Kalsheker","year":"2009","unstructured":"Kalsheker NA. alpha1-antitrypsin deficiency: best clinical practice. J Clin Pathol. 2009;62(10):865\u20139.","journal-title":"J Clin Pathol"},{"issue":"3","key":"648_CR4","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s40139-017-0147-5","volume":"5","author":"EL Mitchell","year":"2017","unstructured":"Mitchell EL, Khan Z. Liver disease in Alpha-1 antitrypsin deficiency: current approaches and future directions. Curr Pathobiol Rep. 2017;5(3):243\u201352.","journal-title":"Curr Pathobiol Rep"},{"issue":"48","key":"648_CR5","doi-asserted-by":"crossref","first-page":"40161","DOI":"10.1074\/jbc.M112.417014","volume":"287","author":"AC Tosello-Trampont","year":"2012","unstructured":"Tosello-Trampont AC, Landes SG, Nguyen V, Novobrantseva TI, Hahn YS. Kuppfer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-alpha production. J Biol Chem. 2012;287(48):40161\u201372.","journal-title":"J Biol Chem"},{"issue":"4","key":"648_CR6","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1172\/JCI113999","volume":"83","author":"JA Carlson","year":"1989","unstructured":"Carlson JA, Rogers BB, Sifers RN, Finegold MJ, Clift SM, DeMayo FJ, et al. Accumulation of PiZ alpha 1-antitrypsin causes liver damage in transgenic mice. J Clin Invest. 1989;83(4):1183\u201390.","journal-title":"J Clin Invest"},{"issue":"6","key":"648_CR7","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.jhep.2018.08.005","volume":"69","author":"VC Clark","year":"2018","unstructured":"Clark VC, Marek G, Liu C, Collinsworth A, Shuster J, Kurtz T, et al. Clinical and histologic features of adults with alpha-1 antitrypsin deficiency in a non-cirrhotic cohort. J Hepatol. 2018;69(6):1357\u201364.","journal-title":"J Hepatol"},{"key":"648_CR8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3389\/fphys.2015.00173","volume":"6","author":"S Lepreux","year":"2015","unstructured":"Lepreux S, Desmouliere A. Human liver myofibroblasts during development and diseases with a focus on portal (myo)fibroblasts. Front Physiol. 2015;6:173.","journal-title":"Front Physiol"},{"issue":"48","key":"648_CR9","doi-asserted-by":"crossref","first-page":"10512","DOI":"10.3748\/wjg.v22.i48.10512","volume":"22","author":"CY Zhang","year":"2016","unstructured":"Zhang CY, Yuan WG, He P, Lei JH, Wang CX. Liver fibrosis and hepatic stellate cells: etiology, pathological hallmarks and therapeutic targets. World J Gastroenterol. 2016;22(48):10512\u201322.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"648_CR10","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jhep.2013.03.028","volume":"59","author":"AI Masyuk","year":"2013","unstructured":"Masyuk AI, Masyuk TV, Larusso NF. Exosomes in the pathogenesis, diagnostics and therapeutics of liver diseases. J Hepatol. 2013;59(3):621\u20135.","journal-title":"J Hepatol"},{"issue":"3","key":"648_CR11","doi-asserted-by":"crossref","first-page":"5338","DOI":"10.3390\/ijms14035338","volume":"14","author":"C Corrado","year":"2013","unstructured":"Corrado C, Raimondo S, Chiesi A, Ciccia F, De Leo G, Alessandro R. Exosomes as intercellular signaling organelles involved in health and disease: basic science and clinical applications. Int J Mol Sci. 2013;14(3):5338\u201366.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"648_CR12","doi-asserted-by":"crossref","first-page":"e49723","DOI":"10.1371\/journal.pone.0049723","volume":"7","author":"J Wahlgren","year":"2012","unstructured":"Wahlgren J, Karlson Tde L, Glader P, Telemo E, Valadi H. Activated human T cells secrete exosomes that participate in IL-2 mediated immune response signaling. PLoS One. 2012;7(11):e49723.","journal-title":"PLoS One"},{"key":"648_CR13","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1750-1172-3-16","volume":"3","author":"L Fregonese","year":"2008","unstructured":"Fregonese L, Stolk J. Hereditary alpha-1-antitrypsin deficiency and its clinical consequences. Orphanet J Rare Dis. 2008;3:16.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"648_CR14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/nar\/gkr688","volume":"40","author":"MR Friedlander","year":"2012","unstructured":"Friedlander MR, Mackowiak SD, Li N, Chen W, Rajewsky N. miRDeep2 accurately identifies known and hundreds of novel microRNA genes in seven animal clades. Nucleic Acids Res. 2012;40(1):37\u201352.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"648_CR15","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.stem.2018.05.027","volume":"23","author":"M Coll","year":"2018","unstructured":"Coll M, Perea L, Boon R, Leite SB, Vallverdu J, Mannaerts I, et al. Generation of hepatic stellate cells from human pluripotent stem cells enables in vitro modeling of liver fibrosis. Cell Stem Cell. 2018;23(1):101\u201313 e7.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"648_CR16","doi-asserted-by":"crossref","first-page":"5998","DOI":"10.1038\/s41598-017-05787-y","volume":"7","author":"M Garcia-Contreras","year":"2017","unstructured":"Garcia-Contreras M, Shah SH, Tamayo A, Robbins PD, Golberg RB, Mendez AJ, et al. Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration type 1 diabetes. Sci Rep. 2017;7(1):5998.","journal-title":"Sci Rep"},{"issue":"3","key":"648_CR17","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/gb-2010-11-3-r25","volume":"11","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, Oshlack A. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol. 2010;11(3):R25.","journal-title":"Genome Biol"},{"key":"648_CR18","first-page":"4223","volume":"9","author":"AB Banizs","year":"2014","unstructured":"Banizs AB, Huang T, Dryden K, Berr SS, Stone JR, Nakamoto RK, et al. In vitro evaluation of endothelial exosomes as carriers for small interfering ribonucleic acid delivery. Int J Nanomedicine. 2014;9:4223\u201330.","journal-title":"Int J Nanomedicine"},{"key":"648_CR19","doi-asserted-by":"crossref","unstructured":"Giriwono PE, Shirakawa H, Ohsaki Y, Sato S, Aoyama Y, Ho HJ, et al. Geranylgeraniol Suppresses the Expression of IRAK1 and TRAF6 to Inhibit NFkappaB Activation in Lipopolysaccharide-Induced Inflammatory Responses in Human Macrophage-Like Cells. Int J Mol Sci. 2019;20(9):2320.","DOI":"10.3390\/ijms20092320"},{"issue":"1","key":"648_CR20","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1038\/s41467-018-04695-7","volume":"9","author":"MKS Tang","year":"2018","unstructured":"Tang MKS, Yue PYK, Ip PP, Huang RL, Lai HC, Cheung ANY, et al. Soluble E-cadherin promotes tumor angiogenesis and localizes to exosome surface. Nat Commun. 2018;9(1):2270.","journal-title":"Nat Commun"},{"issue":"3","key":"648_CR21","first-page":"292","volume":"21","author":"G Li","year":"2018","unstructured":"Li G, Chen T, Zhu Y, Xiao X, Bu J, Huang Z. MiR-103 alleviates autophagy and apoptosis by regulating SOX2 in LPS-injured PC12 cells and SCI rats. Iran J Basic Med Sci. 2018;21(3):292\u2013300.","journal-title":"Iran J Basic Med Sci"},{"issue":"16","key":"648_CR22","doi-asserted-by":"crossref","first-page":"6240","DOI":"10.1074\/jbc.RA118.006142","volume":"294","author":"N Khodayari","year":"2019","unstructured":"Khodayari N, Oshins R, Alli AA, Tuna KM, Holliday LS, Krotova K, et al. Modulation of calreticulin expression reveals a novel exosome-mediated mechanism of Z variant alpha1-antitrypsin disposal. J Biol Chem. 2019;294(16):6240\u201352.","journal-title":"J Biol Chem"},{"issue":"1","key":"648_CR23","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/jcb.27165","volume":"120","author":"X Xue","year":"2019","unstructured":"Xue X, Zhao Y, Wang X, Qin L, Hu R. Development and validation of serum exosomal microRNAs as diagnostic and prognostic biomarkers for hepatocellular carcinoma. J Cell Biochem. 2019;120(1):135\u201342.","journal-title":"J Cell Biochem"},{"issue":"7576","key":"648_CR24","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nature15376","volume":"527","author":"L Zhang","year":"2015","unstructured":"Zhang L, Zhang S, Yao J, Lowery FJ, Zhang Q, Huang WC, et al. Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth. Nature. 2015;527(7576):100\u20134.","journal-title":"Nature."},{"issue":"1","key":"648_CR25","doi-asserted-by":"crossref","first-page":"8973","DOI":"10.1038\/s41598-018-27190-x","volume":"8","author":"W Fitzgerald","year":"2018","unstructured":"Fitzgerald W, Freeman ML, Lederman MM, Vasilieva E, Romero R, Margolis L. A system of cytokines encapsulated in ExtraCellular vesicles. Sci Rep. 2018;8(1):8973.","journal-title":"Sci Rep"},{"issue":"10","key":"648_CR26","doi-asserted-by":"crossref","first-page":"e75692","DOI":"10.1371\/journal.pone.0075692","volume":"8","author":"R Weiskirchen","year":"2013","unstructured":"Weiskirchen R, Weimer J, Meurer SK, Kron A, Seipel B, Vater I, et al. Genetic characteristics of the human hepatic stellate cell line LX-2. PLoS One. 2013;8(10):e75692.","journal-title":"PLoS One"},{"key":"648_CR27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13069-015-0032-y","volume":"8","author":"LC Stone","year":"2015","unstructured":"Stone LC, Thorne LS, Weston CJ, Graham M, Hodges NJ. Cytoglobin expression in the hepatic stellate cell line HSC-T6 is regulated by extracellular matrix proteins dependent on FAK-signalling. Fibrogenesis Tissue Repair. 2015;8:15.","journal-title":"Fibrogenesis Tissue Repair"},{"key":"648_CR28","doi-asserted-by":"crossref","unstructured":"Liu T, Zhang L, Joo D, Sun SC. NF-kappaB signaling in inflammation. Signal Transduct Target Ther. 2017;2.","DOI":"10.1038\/sigtrans.2017.23"},{"key":"648_CR29","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3389\/fphys.2012.00213","volume":"3","author":"Y Saiman","year":"2012","unstructured":"Saiman Y, Friedman SL. The role of chemokines in acute liver injury. Front Physiol. 2012;3:213.","journal-title":"Front Physiol"},{"key":"648_CR30","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1471-2466-14-106","volume":"14","author":"IM Olfert","year":"2014","unstructured":"Olfert IM, Malek MH, Eagan TM, Wagner H, Wagner PD. Inflammatory cytokine response to exercise in alpha-1-antitrypsin deficient COPD patients 'on' or 'off' augmentation therapy. BMC Pulm Med. 2014;14:106.","journal-title":"BMC Pulm Med"},{"issue":"16","key":"648_CR31","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.4254\/wjh.v7.i16.1974","volume":"7","author":"M Dirchwolf","year":"2015","unstructured":"Dirchwolf M, Ruf AE. Role of systemic inflammation in cirrhosis: from pathogenesis to prognosis. World J Hepatol. 2015;7(16):1974\u201381.","journal-title":"World J Hepatol"},{"issue":"3","key":"648_CR32","doi-asserted-by":"crossref","first-page":"e0172983","DOI":"10.1371\/journal.pone.0172983","volume":"12","author":"N Khodayari","year":"2017","unstructured":"Khodayari N, Wang RL, Marek G, Krotova K, Kirst M, Liu C, et al. SVIP regulates Z variant alpha-1 antitrypsin retro-translocation by inhibiting ubiquitin ligase gp78. PLoS One. 2017;12(3):e0172983.","journal-title":"PLoS One"},{"issue":"1","key":"648_CR33","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s40478-017-0467-z","volume":"5","author":"YJ Lim","year":"2017","unstructured":"Lim YJ, Lee SJ. Are exosomes the vehicle for protein aggregate propagation in neurodegenerative diseases? Acta Neuropathol Commun. 2017;5(1):64.","journal-title":"Acta Neuropathol Commun"},{"issue":"6","key":"648_CR34","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.trsl.2010.12.014","volume":"157","author":"S Ottaviani","year":"2011","unstructured":"Ottaviani S, Gorrini M, Scabini R, Kadija Z, Paracchini E, Mariani F, et al. C reactive protein and alpha1-antitrypsin: relationship between levels and gene variants. Transl Res. 2011;157(6):332\u20138.","journal-title":"Transl Res"},{"issue":"3","key":"648_CR35","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1586\/1744666X.4.3.379","volume":"4","author":"A Peisajovich","year":"2008","unstructured":"Peisajovich A, Marnell L, Mold C, Du Clos TW. C-reactive protein at the interface between innate immunity and inflammation. Expert Rev Clin Immunol. 2008;4(3):379\u201390.","journal-title":"Expert Rev Clin Immunol"},{"issue":"4","key":"648_CR36","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1164\/rccm.201403-0529OC","volume":"191","author":"S Baraldo","year":"2015","unstructured":"Baraldo S, Turato G, Lunardi F, Bazzan E, Schiavon M, Ferrarotti I, et al. Immune activation in alpha1-antitrypsin-deficiency emphysema. Beyond the protease-antiprotease paradigm. Am J Respir Crit Care Med. 2015;191(4):402\u20139.","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"648_CR37","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.bcp.2011.12.037","volume":"83","author":"S Pant","year":"2012","unstructured":"Pant S, Hilton H, Burczynski ME. The multifaceted exosome: biogenesis, role in normal and aberrant cellular function, and frontiers for pharmacological and biomarker opportunities. Biochem Pharmacol. 2012;83(11):1484\u201394.","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"648_CR38","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/hep.27332","volume":"61","author":"E Seki","year":"2015","unstructured":"Seki E, Schwabe RF. Hepatic inflammation and fibrosis: functional links and key pathways. Hepatology. 2015;61(3):1066\u201379.","journal-title":"Hepatology."},{"issue":"3","key":"648_CR39","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3390\/ijms17030280","volume":"17","author":"CN Hayes","year":"2016","unstructured":"Hayes CN, Chayama K. MicroRNAs as biomarkers for liver disease and hepatocellular carcinoma. Int J Mol Sci. 2016;17(3):280.","journal-title":"Int J Mol Sci"},{"key":"648_CR40","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.2147\/COPD.S145445","volume":"12","author":"C Esquinas","year":"2017","unstructured":"Esquinas C, Janciauskiene S, Gonzalo R, Mas de Xaxars G, Olejnicka B, Belmonte I, et al. Gene and miRNA expression profiles in PBMCs from patients with severe and mild emphysema and PiZZ alpha1-antitrypsin deficiency. Int J Chron Obstruct Pulmon Dis. 2017;12:3381\u201390.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"648_CR41","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.omtn.2018.04.016","volume":"12","author":"K You","year":"2018","unstructured":"You K, Li SY, Gong J, Fang JH, Zhang C, Zhang M, et al. MicroRNA-125b promotes hepatic stellate cell activation and liver fibrosis by activating RhoA signaling. Mol Ther Nucleic Acids. 2018;12:57\u201366.","journal-title":"Mol Ther Nucleic Acids"},{"key":"648_CR42","doi-asserted-by":"crossref","unstructured":"Kitano M, Bloomston PM. Hepatic Stellate Cells and microRNAs in Pathogenesis of Liver Fibrosis. J Clin Med. 2016;5(3).","DOI":"10.3390\/jcm5030038"},{"issue":"7","key":"648_CR43","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/s41419-018-0752-1","volume":"9","author":"L Ma","year":"2018","unstructured":"Ma L, Yang X, Wei R, Ye T, Zhou JK, Wen M, et al. MicroRNA-214 promotes hepatic stellate cell activation and liver fibrosis by suppressing Sufu expression. Cell Death Dis. 2018;9(7):718.","journal-title":"Cell Death Dis"},{"key":"648_CR44","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.phymed.2018.10.027","volume":"57","author":"PW Yang","year":"2019","unstructured":"Yang PW, Lu ZY, Pan Q, Chen TT, Feng XJ, Wang SM, et al. MicroRNA-6809-5p mediates luteolin-induced anticancer effects against hepatoma by targeting flotillin 1. Phytomedicine. 2019;57:18\u201329.","journal-title":"Phytomedicine."},{"issue":"3","key":"648_CR45","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.bbrc.2015.08.012","volume":"465","author":"L Lu","year":"2015","unstructured":"Lu L, Wang J, Lu H, Zhang G, Liu Y, Wang J, et al. MicroRNA-130a and -130b enhance activation of hepatic stellate cells by suppressing PPARgamma expression: a rat fibrosis model study. Biochem Biophys Res Commun. 2015;465(3):387\u201393.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"648_CR46","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/jcp.24486","volume":"229","author":"S Pan","year":"2014","unstructured":"Pan S, Yang X, Jia Y, Li R, Zhao R. Microvesicle-shuttled miR-130b reduces fat deposition in recipient primary cultured porcine adipocytes by inhibiting PPAR-g expression. J Cell Physiol. 2014;229(5):631\u20139.","journal-title":"J Cell Physiol"},{"key":"648_CR47","doi-asserted-by":"crossref","first-page":"11916","DOI":"10.1038\/ncomms11916","volume":"7","author":"D Yang","year":"2016","unstructured":"Yang D, Yuan Q, Balakrishnan A, Bantel H, Klusmann JH, Manns MP, et al. MicroRNA-125b-5p mimic inhibits acute liver failure. Nat Commun. 2016;7:11916.","journal-title":"Nat Commun"},{"issue":"6","key":"648_CR48","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.jhep.2015.07.037","volume":"63","author":"ZC Zhang","year":"2015","unstructured":"Zhang ZC, Liu Y, Xiao LL, Li SF, Jiang JH, Zhao Y, et al. Upregulation of miR-125b by estrogen protects against non-alcoholic fatty liver in female mice. J Hepatol. 2015;63(6):1466\u201375.","journal-title":"J Hepatol"},{"issue":"3","key":"648_CR49","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.ajpath.2013.11.008","volume":"184","author":"F Meng","year":"2014","unstructured":"Meng F, Onori P, Hargrove L, Han Y, Kennedy L, Graf A, et al. Regulation of the histamine\/VEGF axis by miR-125b during cholestatic liver injury in mice. Am J Pathol. 2014;184(3):662\u201373.","journal-title":"Am J Pathol"},{"issue":"5","key":"648_CR50","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1002\/hep.23904","volume":"52","author":"L Liang","year":"2010","unstructured":"Liang L, Wong CM, Ying Q, Fan DN, Huang S, Ding J, et al. MicroRNA-125b suppressesed human liver cancer cell proliferation and metastasis by directly targeting oncogene LIN28B2. Hepatology. 2010;52(5):1731\u201340.","journal-title":"Hepatology."},{"key":"648_CR51","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fphys.2012.00049","volume":"3","author":"A Noetel","year":"2012","unstructured":"Noetel A, Kwiecinski M, Elfimova N, Huang J, Odenthal M. microRNA are Central Players in Anti- and Profibrotic Gene Regulation during Liver Fibrosis. Front Physiol. 2012;3:49.","journal-title":"Front Physiol"},{"issue":"5","key":"648_CR52","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1091\/mbc.e13-07-0382","volume":"25","author":"TH Lee","year":"2014","unstructured":"Lee TH, McKleroy W, Khalifeh-Soltani A, Sakuma S, Lazarev S, Riento K, et al. Functional genomic screen identifies novel mediators of collagen uptake. Mol Biol Cell. 2014;25(5):583\u201393.","journal-title":"Mol Biol Cell"},{"issue":"33","key":"648_CR53","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.3748\/wjg.v25.i33.4835","volume":"25","author":"HJ Zhangdi","year":"2019","unstructured":"Zhangdi HJ, Su SB, Wang F, Liang ZY, Yan YD, Qin SY, et al. Crosstalk network among multiple inflammatory mediators in liver fibrosis. World J Gastroenterol. 2019;25(33):4835\u201349.","journal-title":"World J Gastroenterol"},{"key":"648_CR54","doi-asserted-by":"crossref","unstructured":"Liu R, Li X, Zhu W, Wang Y, Zhao D, Wang X, et al. Cholangiocyte-derived Exosomal long noncoding RNA H19 promotes hepatic stellate cell activation and Cholestatic liver fibrosis. Hepatology. 2019.","DOI":"10.1002\/hep.30662"},{"issue":"6","key":"648_CR55","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00535-016-1190-4","volume":"51","author":"T Greuter","year":"2016","unstructured":"Greuter T, Shah VH. Hepatic sinusoids in liver injury, inflammation, and fibrosis: new pathophysiological insights. J Gastroenterol. 2016;51(6):511\u20139.","journal-title":"J Gastroenterol"},{"issue":"7","key":"648_CR56","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","volume":"14","author":"T Tsuchida","year":"2017","unstructured":"Tsuchida T, Friedman SL. Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol. 2017;14(7):397\u2013411.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"52","key":"648_CR57","doi-asserted-by":"crossref","first-page":"30684","DOI":"10.1074\/jbc.M115.671735","volume":"290","author":"R Wang","year":"2015","unstructured":"Wang R, Ding Q, Yaqoob U, de Assuncao TM, Verma VK, Hirsova P, et al. Exosome adherence and internalization by hepatic stellate cells triggers Sphingosine 1-phosphate-dependent migration. J Biol Chem. 2015;290(52):30684\u201396.","journal-title":"J Biol Chem"},{"issue":"1","key":"648_CR58","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0168-8278(00)80159-2","volume":"33","author":"A Lang","year":"2000","unstructured":"Lang A, Schoonhoven R, Tuvia S, Brenner DA, Rippe RA. Nuclear factor kappaB in proliferation, activation, and apoptosis in rat hepatic stellate cells. J Hepatol. 2000;33(1):49\u201358.","journal-title":"J Hepatol"},{"issue":"5","key":"648_CR59","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.jhep.2017.06.001","volume":"67","author":"CR Gandhi","year":"2017","unstructured":"Gandhi CR. Hepatic stellate cell activation and pro-fibrogenic signals. J Hepatol. 2017;67(5):1104\u20135.","journal-title":"J Hepatol"},{"issue":"46","key":"648_CR60","doi-asserted-by":"crossref","first-page":"18490","DOI":"10.1073\/pnas.1309718110","volume":"110","author":"CC Scholz","year":"2013","unstructured":"Scholz CC, Cavadas MA, Tambuwala MM, Hams E, Rodriguez J, von Kriegsheim A, et al. Regulation of IL-1beta-induced NF-kappaB by hydroxylases links key hypoxic and inflammatory signaling pathways. Proc Natl Acad Sci U S A. 2013;110(46):18490\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"648_CR61","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.smim.2014.05.004","volume":"26","author":"MS Hayden","year":"2014","unstructured":"Hayden MS, Ghosh S. Regulation of NF-kappaB by TNF family cytokines. Semin Immunol. 2014;26(3):253\u201366.","journal-title":"Semin Immunol"},{"issue":"1","key":"648_CR62","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","volume":"88","author":"SL Friedman","year":"2008","unstructured":"Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev. 2008;88(1):125\u201372.","journal-title":"Physiol Rev"},{"issue":"3","key":"648_CR63","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1055\/s-0030-1255351","volume":"30","author":"HE Wasmuth","year":"2010","unstructured":"Wasmuth HE, Tacke F, Trautwein C. Chemokines in liver inflammation and fibrosis. Semin Liver Dis. 2010;30(3):215\u201325.","journal-title":"Semin Liver Dis"},{"issue":"38","key":"648_CR64","doi-asserted-by":"crossref","first-page":"29101","DOI":"10.1074\/jbc.M109.099952","volume":"285","author":"DL Clarke","year":"2010","unstructured":"Clarke DL, Clifford RL, Jindarat S, Proud D, Pang L, Belvisi M, et al. TNFalpha and IFNgamma synergistically enhance transcriptional activation of CXCL10 in human airway smooth muscle cells via STAT-1, NF-kappaB, and the transcriptional coactivator CREB-binding protein. J Biol Chem. 2010;285(38):29101\u201310.","journal-title":"J Biol Chem"},{"issue":"21","key":"648_CR65","first-page":"343","volume":"3","author":"M Rashighi","year":"2015","unstructured":"Rashighi M, Harris JE. Interfering with the IFN-gamma\/CXCL10 pathway to develop new targeted treatments for vitiligo. Ann Transl Med. 2015;3(21):343.","journal-title":"Ann Transl Med"},{"issue":"2","key":"648_CR66","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1600-0676.1991.tb00499.x","volume":"11","author":"T Nouchi","year":"1991","unstructured":"Nouchi T, Tanaka Y, Tsukada T, Sato C, Marumo F. Appearance of alpha-smooth-muscle-actin-positive cells in hepatic fibrosis. Liver. 1991;11(2):100\u20135.","journal-title":"Liver."},{"issue":"5","key":"648_CR67","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.dld.2004.11.009","volume":"37","author":"G Carpino","year":"2005","unstructured":"Carpino G, Morini S, Ginanni Corradini S, Franchitto A, Merli M, Siciliano M, et al. Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation. Dig Liver Dis. 2005;37(5):349\u201356.","journal-title":"Dig Liver Dis"},{"issue":"12","key":"648_CR68","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1136\/gutjnl-2017-315846","volume":"67","author":"J Mann","year":"2018","unstructured":"Mann J, Reeves HL, Feldstein AE. Liquid biopsy for liver diseases. Gut. 2018;67(12):2204\u201312.","journal-title":"Gut."},{"issue":"10","key":"648_CR69","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1111\/j.1572-0241.2002.06038.x","volume":"97","author":"A Regev","year":"2002","unstructured":"Regev A, Berho M, Jeffers LJ, Milikowski C, Molina EG, Pyrsopoulos NT, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol. 2002;97(10):2614\u20138.","journal-title":"Am J Gastroenterol"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-020-00648-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-020-00648-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-020-00648-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T20:03:42Z","timestamp":1630699422000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-020-00648-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,4]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["648"],"URL":"https:\/\/doi.org\/10.1186\/s12964-020-00648-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-29308\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-29308\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-29308\/v3","asserted-by":"object"}]},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,4]]},"assertion":[{"value":"14 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All patients gave informed, written consent prior to enrolling. The study was approved by the University of Florida institutional IRB and is listed at\n                      \n                      (NCT01810458).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"140"}}